Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹498 Cr₹532 Cr₹662 Cr₹392 Cr₹84 Cr

What is the latest Consolidated Net Profit of EMCURE PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of EMCURE PHARMACEUTICALS is ₹498 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹498 Cr
Mar2023₹532 Cr
Mar2022₹662 Cr
Mar2021₹392 Cr
Mar2020₹84 Cr

How is Consolidated Net Profit of EMCURE PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹498 Cr
-6.36
Mar2023 ₹532 Cr
-19.66
Mar2022 ₹662 Cr
68.87
Mar2021 ₹392 Cr
369.04
Mar2020 ₹84 Cr -

Compare Consolidated Net Profit of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹20,743.6 Cr 20.9% 18.2% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,390.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

20.9%

18.2%

NA
SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses